In: Operations Management
Solution -
The clinical trials of Vigor was published in the year 2000 by the New England Journal of Medicine. In the clinical trials, it was found first interpreted and presented in a biased manner to be an effective drug and was marketed across to many physicians.
Later it was found that this drug created a heightened risk of cardiovascular disorder. The people who had consumed this drug were tested on such an issue. This led to the marketing and sales team to act briskly on the cardiovascular card system to provide evidence on the contrary. But the damage had been done and the controversy of a scam was brought to light.